Inhibition of raf kinase using substituted heterocyclic ureas

Details Inhibition of raf kinase using substituted heterocyclic ureas Inhibition of raf kinase using substituted heterocyclic ureas

C - Chemistry, Metallurgy

07

D

C07D 417/12 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) A61K 31/41 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/425 (2006.01) A61K 31/44 (2006.01) C07D 231/40 (2006.01) C07D 257/06 (2006.01) C07D 261/14 (2006.01) C07D 263/48 (2006.01) C07D 271/113 (2006.01) C07D 277/28 (2006.01) C07D 285/135 (2006.01) C07D 307/66 (2006.01) C07D 333/36 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2315717

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

L'invention a trait à des méthodes de traitement de tumeurs induites par la raf kinase, au moyen de composés d'urées substituées, et à ces composés en soi.

Affiliated with

Also associated with

Rating

Inhibition of raf kinase using substituted heterocyclic ureas does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of raf kinase using substituted heterocyclic ureas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of raf kinase using substituted heterocyclic ureas will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1852255